These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 34034478)
1. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy]. Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478 [No Abstract] [Full Text] [Related]
2. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470 [TBL] [Abstract][Full Text] [Related]
3. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model. Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686 [TBL] [Abstract][Full Text] [Related]
4. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy]. Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer]. Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307 [No Abstract] [Full Text] [Related]
6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
7. [Long-term conditional disease-free survival for rectal cancer patients underwent neoadjuvant chemoradiotherapy]. Shen SH; Wu YL; Li DD; Zhang QQ; Feng L; Fang H; Zhu YL; Zhang HZ Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1304-1309. PubMed ID: 34915641 [No Abstract] [Full Text] [Related]
8. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study. Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer]. Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy. Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172 [TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs. Tang YL; Li DD; Duan JY; Wang X Int J Colorectal Dis; 2024 Jun; 39(1):93. PubMed ID: 38896374 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy. Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram. Sun Y; Zhang Y; Huang Z; Chi P J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy. Arslan A; Akay E; Turk G; Eren SK J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognostic analysis of patients with pathological complete response and near complete response after neoadjuvant treatment of rectal cancer]. Li DD; Zhang QQ; Wu YL; Shen SH; Fang H; Zhu YL; Zhang HZ Zhonghua Yi Xue Za Zhi; 2021 May; 101(18):1357-1362. PubMed ID: 34015870 [No Abstract] [Full Text] [Related]
16. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy. Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522 [TBL] [Abstract][Full Text] [Related]
17. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy]. Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824 [No Abstract] [Full Text] [Related]
18. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer. Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model. Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455 [TBL] [Abstract][Full Text] [Related]
20. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study. Liao YT; Lin YL; Huang J; Hung JS; Lin BR Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]